|
Volumn 69, Issue 6, 2002, Pages 501-504
|
Update on kidney transplantation: Increasing clinical success, expanding waiting lists
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOSPORIN;
CYCLOSPORIN A;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FINGOLIMOD;
GLUCOCORTICOID;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
RAPAMYCIN;
RECOMBINANT ERYTHROPOIETIN;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ANEMIA;
ARTICLE;
BLOOD TRANSFUSION;
CARDIOTOXICITY;
CARDIOVASCULAR DISEASE;
CLINICAL PRACTICE;
CONTROLLED STUDY;
DONOR;
DRUG BLOOD LEVEL;
DRUG ELIMINATION;
DRUG FORMULATION;
DRUG POTENCY;
DRUG WITHDRAWAL;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
NEPHROTOXICITY;
SENSITIZATION;
|
EID: 0036088737
PISSN: 08911150
EISSN: None
Source Type: Journal
DOI: 10.3949/ccjm.69.6.501 Document Type: Article |
Times cited : (6)
|
References (15)
|